Results 261 to 270 of about 136,697 (349)

Buprenorphine and Surface-based Brain Morphometry: Impacts on Cortical Thickness, Depth, and Gyrification in Patients with Opioid Use Disorder

Abhishek Ghosh, Abhishek Verma, Simranjit Kaur, Chirag Ahuja, Ritu Nehra, Paramjit Singh, Manish Modi, S Senthil Kumaran, Debasish Basu   +8 more
openalex   +1 more source

Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference‐in‐differences time series

Addiction, EarlyView.
Abstract Background and aims Evidence regarding the impacts of supervised drug consumption services (SDC) remains mixed, and few evaluations have used individual‐level, linkable health data to examine service withdrawal. In September 2024, the Red Deer overdose prevention site (OPS) in Alberta, Canada, was scheduled for closure, with operations ceasing
Nathaniel Day, Kym Kaufmann, Daniel John Alexander Devoe, Vanja Grubac, Alessia DiMarzo, Haisa Osmanli, Vanessa Norton, Shelly Vik, Nickie Mathew, Robert Lawrence Tanguay, Anees Bahji   +10 more
wiley   +1 more source

Collaborative Management of Opioid Use Disorder and Cancer Care in a Patient With Medical Complexity and Housing Instability. [PDF]

Cureus
Abrams EA, Williams M.
europepmc   +1 more source

Mental Health and the Constitution: How Incarcerating the Mentally Ill Might Pave the Way to Treatment

, 2020
Caspar, Samantha M., Joukov, Artem M.
core  

Regional perspectives: Substance use related problems in Ethiopia

Addiction, EarlyView.
Abstract Ethiopia, with a population exceeding 130 million, presents a complex landscape for understanding substance use disorders. The country's diverse cultural heritage, varying regional practices, and evolving socioeconomic conditions create unique factors of substance use that differ markedly from global trends.
Tesfa M. Yimer, Wubalem Fekadu, Janni Leung, Awoke Mihretu, Solomon Teferra   +4 more
wiley   +1 more source

Medications for Opioid Use Disorder in County Jails - Outcomes after Release. [PDF]

N Engl J Med
Berk J, Rich J.
europepmc   +1 more source

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

Addiction, EarlyView.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier, Heidar Sharafi, Adam Bisaga, Didier Jutras‐Aswad   +3 more
wiley   +1 more source

Methadone Dose and Patient-Directed Discharge in Hospitalized Patients With Opioid Use Disorder.

JAMA Netw Open
Meredith RR, Garneau WM, Feder KA, Buresh ME.   +3 more
europepmc   +1 more source

Buprenorphine Use and the Risk of Dental Adverse Events in Patients With Opioid Use Disorder. [PDF]

Subst Use
Okeke CM, Okonkwo M, Olateju O, Saponjac VT, Hu M, Singh R, Mursalin M, Thornton JD.   +7 more
europepmc   +1 more source